Home>Commensal bacterial hybrid nanovesicles improve immune checkpoint therapy in pancreatic cancer through immune and metabolic reprogramming
Commensal bacterial hybrid nanovesicles improve immune checkpoint therapy in pancreatic cancer through immune and metabolic reprogramming
- Impact factors: 5.988
- Publication: Frontiers in Pharmacology
- Author:Ling-Fei Kong, Xiao-Juan Rong, Pan Yan, Tuo Qin, Xiao-Hui Zhang, Yu-Tong Kang, Bo Cheng, Wen-Ling Su, Tian-Le Gao, Cai Tie
- DOI citation-doi:10.3389/fphar.2023.1066643
- Date:2023-03-02